↓ Skip to main content

Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study

Overview of attention for article published in Frontiers in oncology, March 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study
Published in
Frontiers in oncology, March 2020
DOI 10.3389/fonc.2020.00202
Pubmed ID
Authors

Francesca Urbani, Virginia Ferraresi, Imerio Capone, Iole Macchia, Belinda Palermo, Carmen Nuzzo, Angela Torsello, Patrizio Pezzotti, Diana Giannarelli, Anna Fausta Pozzi, Mariano Santaquilani, Paolo Roazzi, Silvia Bastucci, Caterina Catricalà, Antonia La Malfa, Giuseppe Vercillo, Novella Gualtieri, Carla Buccione, Luciano Castiello, Francesco Cognetti, Paola Nisticò, Filippo Belardelli, Federica Moschella, Enrico Proietti

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 28%
Other 3 10%
Lecturer 2 7%
Student > Bachelor 2 7%
Student > Ph. D. Student 1 3%
Other 1 3%
Unknown 12 41%
Readers by discipline Count As %
Medicine and Dentistry 8 28%
Immunology and Microbiology 4 14%
Biochemistry, Genetics and Molecular Biology 2 7%
Business, Management and Accounting 1 3%
Agricultural and Biological Sciences 1 3%
Other 0 0%
Unknown 13 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2020.
All research outputs
#21,011,157
of 25,806,763 outputs
Outputs from Frontiers in oncology
#11,541
of 22,805 outputs
Outputs of similar age
#297,061
of 389,280 outputs
Outputs of similar age from Frontiers in oncology
#245
of 486 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,805 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 389,280 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 486 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.